Influence of SREBP-2 and SCAP Gene Polymorphisms on Lipid-Lowering Response to Atorvastatin in a Cohort of Chilean Subjects with Amerindian Background-Reference-Cited by-同舟云学术

Influence of SREBP-2 and SCAP Gene Polymorphisms on Lipid-Lowering Response to Atorvastatin in a Cohort of Chilean Subjects with Amerindian Background

Published:2014-03-11 Issue:4 Volume:18 Page:435-443
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Lagos Jenny,Zambrano Tomás,Rosales Alexy,Salazar Luis A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40291-014-0094-3.pdf

Reference51 articles.

1. Mennickent S, Bravo M, Calvo C, Avello LM. Pleitropic effects of statins. Rev Med Chile. 2008;136:775–82.

2. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004; 109; III-39–III-43.

3. Bucher H, Griffich L, Guyatt G. Systematic review on the risk and benefit of different cholesterol lowering interventions. Arteroscler Thromb Vasc Biol. 1999;19:187–95.

4. Vaughan CJ, Gotto AM, Basson CT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 2000;35:1–10.

5. Istvan E. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductasa. Am Heart J. 2002;144(527):532.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial Genetic Background May Impact Statins Side Effects and Atherosclerosis Development in Familial Hypercholesterolemia;International Journal of Molecular Sciences;2022-12-28

2. Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study;Pharmaceuticals;2020-11-12

3. Evaluation of hypolipidemic peptide (Val-Phe-Val-Arg-Asn) virtual screened from chickpea peptides by pharmacophore model in high-fat diet-induced obese rat;Journal of Functional Foods;2019-03

4. Pharmacoepigenetics of Statins;Pharmacoepigenetics;2019

5. Effect of genetic polymorphisms in SREBF–SCAP pathway on therapeutic response to rosuvastatin in Saudi metabolic syndrome patients;Pharmacogenomics;2018-02